Kehua Biotech (002022.SZ) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 443 million yuan, a year-on-year decrease of 46.79%; net loss attributable to shareholders of listed companies of 288.215 million yuan; net loss attributable to shareholders of listed companies deducted 39,166 million yuan from non-recurring profit and loss; and a basic loss of 0.0568 yuan/share per share.
科华生物(002022.SZ)发一季度业绩，净亏损2882.15万元
Kehua Biotech (002022.SZ) reported first-quarter results with a net loss of RMB 28.8215 million
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.